Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy

被引:1273
作者
Imamura, H
Matsuyama, Y
Tanaka, E
Ohkubo, T
Hasegawa, K
Miyagawa, S
Sugawara, Y
Minagawa, M
Takayama, T
Kawasaki, S
Makuuchi, M
机构
[1] Univ Tokyo, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg,Bunkyo Ku, Tokyo 1138655, Japan
[2] Shinshu Univ, Sch Med, Dept Surg 1, Matsumoto, Nagano 390, Japan
[3] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan
[4] Shinshu Univ, Sch Med, Dept Med 2, Matsumoto, Nagano 390, Japan
关键词
hepatocellular carcinoma; intrahepatic recurrence; hepatectomy; metastasis; multicentric occurrence;
D O I
10.1016/S0168-8278(02)00360-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundlAims: We conducted a retrospective cohort study to investigate factors to early and late phase recurrence of hepatocellular carcinoma (HCC). Methods: The study population consisted of 249 patients including 157 with cirrhosis who underwent hepatectomy for HCC. The endpoint was time-to-recurrence. Using a Cox regression model, factors to early and late phase recurrences were investigated censoring recurrence-free patients at the 2-year time point and in patients without recurrence at 2 years. Results: Actuarial probability of overall recurrence at 1, 3, and 5 years were 0.301, 0.623, and 0.790, respectively, with a median follow-up of 624 days. Early recurrence was observed in 123 out of 249 patients; while late recurrence was found in 61 out of 113 patients. Factors to early recurrence were as follows: non-anatomical resection, presence of microscopic vascular invasion, and serum alpha-fetoprotein level greater than or equal to32 ng/ml. Those contributing to late phase recurrence were higher grade of hepatitis activity, multiple tumors, and gross tumor classification. Conclusions: Variables associated with metastatic recurrence were factors to early phase recurrence; whereas those related with elevated carcinogenesis contributed to late phase recurrence, thus providing an epidemiological evidence that different mechanisms, i.e. metastasis and de novo, are involved in intrahepatic recurrence after hepatectomy for HCC. (C) 2002 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:200 / 207
页数:8
相关论文
共 41 条
  • [21] RANDOMIZED TRIAL OF EFFECTS OF INTERFERON-ALPHA ON INCIDENCE OF HEPATOCELLULAR-CARCINOMA IN CHRONIC ACTIVE HEPATITIS-C WITH CIRRHOSIS
    NISHIGUCHI, S
    KUROKI, T
    NAKATANI, S
    MORIMOTO, H
    TAKEDA, T
    NAKAJIMA, S
    SHIOMI, S
    SEKI, S
    KOBAYASHI, K
    OTANI, S
    [J]. LANCET, 1995, 346 (8982) : 1051 - 1055
  • [22] Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
    Poon, RTP
    Fan, ST
    Wong, J
    [J]. ANNALS OF SURGERY, 2000, 232 (01) : 10 - 24
  • [23] Natural history of liver fibrosis progression in patients with chronic hepatitis C
    Poynard, T
    Bedossa, P
    Opolon, P
    [J]. LANCET, 1997, 349 (9055) : 825 - 832
  • [24] Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma
    Regimbeau, JM
    Kianmanesh, R
    Farges, O
    Dondero, F
    Sauvanet, A
    Belghiti, J
    [J]. SURGERY, 2002, 131 (03) : 311 - 317
  • [25] PREOPERATIVE SERUM IMMUNOSUPPRESSIVE ACIDIC PROTEIN (IAP) TEST FOR THE PROGNOSIS OF GASTRIC-CANCER - A STATISTICAL STUDY OF THE THRESHOLD LEVEL AND EVALUATION OF THE EFFECT OF THE BIOLOGICAL RESPONSE MODIFIER PSK
    SAKAMOTO, J
    KOIKE, A
    SAJI, S
    TERAMUKAI, S
    OHASHI, Y
    NAKAZATO, H
    [J]. SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1992, 22 (06): : 530 - 536
  • [26] Early hepatocellular carcinoma as an entity with a high rate of surgical cure
    Takayama, T
    Makuuchi, M
    Hirohashi, S
    Sakamoto, M
    Yamamoto, J
    Shimada, K
    Kosuge, T
    Okada, S
    Takayasu, K
    Yamasaki, S
    [J]. HEPATOLOGY, 1998, 28 (05) : 1241 - 1246
  • [27] Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial
    Takayama, T
    Sekine, T
    Makuuchi, M
    Yamasaki, S
    Kosuge, T
    Yamamoto, J
    Shimada, K
    Sakamoto, M
    Hirohashi, S
    Ohashi, Y
    Kakizoe, T
    [J]. LANCET, 2000, 356 (9232) : 802 - 807
  • [28] TAKENAKA K, 1995, HEPATOLOGY, V22, P20, DOI 10.1002/hep.1840220104
  • [29] Tarao K, 1997, CANCER, V79, P688, DOI 10.1002/(SICI)1097-0142(19970215)79:4<688::AID-CNCR5>3.0.CO
  • [30] 2-A